Clinical Trials List
2025-07-15 - 2029-11-13
Phase II/III
Recruiting4
ICD-10C25.0
Malignant neoplasm of head of pancreas
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9157.0
Malignant neoplasm of head of pancreas
-
Trial Applicant
BRISTOL-MYERS SQUIBB (TAIWAN) LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 陳珈妤 Division of Hematology & Oncology
- Chang-Fang Chiu Division of General Internal Medicine
- Chi-Ching Chen Division of Hematology & Oncology
- 王秀慈 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃文冠 無
- 陳建銘 無
- Po-Jung Su 無
- Chan-Keng Yang 無
- 湯文誠 無
- Jen-Shi Chen 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shao-Jung Hsu Division of General Internal Medicine
- 唐振育 Division of General Internal Medicine
- Ming-Huang Chen Division of Hematology & Oncology
- Yi-Ping Hung Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 呂理駿 無
- Kun-Huei Yeh 無
- Hsiang-Fong Kao 無
- Chiun Hsu 無
- WEI-LI MA 無
- Chia-Chi Lin 無
- SHIH-HUNG YANG 無
- YU-YUN SHAO 無
- Ann-Lii Cheng 無
- TSUNG-HAO LIU 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
18 participants
-
Global
470 participants
